|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print December 10, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00379.2002
Submitted on August 26, 2002
Accepted on November 7, 2002
1 Department of Internal Medicine and Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA
* To whom correspondence should be addressed. E-mail: sklein{at}im.wustl.edu.
The effects of obesity and weight loss on lipoprotein kinetics were evaluated in 6 lean women (BMI: 21±1 kg/m2) and 7 women with abdominal obesity (BMI: 36±1 kg/m2). Stable isotope tracer techniques, in conjunction with compartmental modeling, were used to determine VLDL-triglyceride (TG) and apolipoprotein B-100 (apoB-100) secretion rates in lean women and in obese women before and after 10% weight loss. VLDL-TG and VLDL-apoB-100 secretion rates were similar in lean and obese women. Weight loss decreased the rate of VLDL-TG secretion by ~40% (from 0.41±0.05 to 0.23±0.03 µmol.kg FFM-1.min-1; p<0.05). The relative decline in VLDL-TG produced from non-systemic fatty acids, derived from intraperitoneal and intrahepatic TG, was greater (61±7%) than the decline in VLDL-TG produced from systemic fatty acids, predominately derived from subcutaneous TG, (25±8 %; p<0.05). Weight loss did not affect VLDL-apoB-100 secretion rate. We conclude that weight-loss decreases the rate of VLDL-TG secretion in women with abdominal obesity, primarily by decreasing the availability of non-systemic fatty acids. There is a dissociation in the effect of weight loss on VLDL-TG and apoB-100 metabolic pathways, which may affect VLDL particle size.
This article has been cited by other articles:
![]() |
E. Fabbrini, F. Magkos, B. S. Mohammed, T. Pietka, N. A. Abumrad, B. W. Patterson, A. Okunade, and S. Klein Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity PNAS, September 8, 2009; 106(36): 15430 - 15435. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Gormsen, B. Nellemann, L. P. Sorensen, M. D. Jensen, J. S. Christiansen, and S. Nielsen Impact of body composition on very-low-density lipoprotein-triglycerides kinetics Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E165 - E173. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1568 - E1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, B. W. Patterson, and B. Mittendorfer Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics J. Lipid Res., May 1, 2007; 48(5): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, B. W. Patterson, and B. Mittendorfer No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1243 - E1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen Energy expenditure, insulin, and VLDL-triglyceride production in humans J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Parhofer and P. H. R. Barrett Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies J. Lipid Res., August 1, 2006; 47(8): 1620 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Isley, J. M. Miles, B. W. Patterson, and W. S. Harris The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus J. Lipid Res., January 1, 2006; 47(1): 193 - 200. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |